K-Beauty Stocks: The Listed Companies Behind the Brands Americans Buy

In 2025 the United States became the largest market for Korean cosmetics for the first time, taking $2.2 billion of Korea's $11.4 billion in exports. One brand, Medicube, now sells through Target, Walmart, Costco and Amazon.
An investor who sees those shelves and wants a piece of the trend runs into two problems: many of the brands are not listed, and the listed ones did not all follow the sales. Which stocks give that exposure, and what kind?
The short answer
Many of the best-known names in the US are private. The listed companies fall into three groups: brand owners, contract manufacturers that make products for many brands, and distributors such as Silicon2.
- Beauty of Joseon, TirTir and Round Lab belong to Goodai Global, a private company, so their growth is out of reach for stock investors. Dr.Jart+ belongs to Estée Lauder (NYSE: EL).
- Medicube's owner APR, Laneige's owner Amorepacific and d'Alba's owner d'Alba Global are listed in Seoul.
- In 2026 the two big contract manufacturers, Cosmax and Korea Kolmar, rose more than 60%. Five of the seven brand owners we tracked fell.
Who owns the brands
| Brand | Owner | Listed? |
|---|---|---|
| Medicube | APR | Seoul, KOSPI 278470 |
| Laneige, Sulwhasoo, COSRX | Amorepacific | Seoul, KOSPI 090430 |
| Innisfree | Amorepacific Holdings (subsidiary) | Holding company in Seoul, KOSPI 002790 |
| d'Alba | d'Alba Global | Seoul, KOSPI 483650 |
| VT (Reedle Shot) | VT | Seoul, KOSDAQ 018290 |
| Beauty of Joseon, TirTir, Round Lab | Goodai Global | Private |
| Dr.Jart+ | Estée Lauder | NYSE: EL |
Ownership is from company releases and the trade press. Goodai Global says it completed its purchase of Round Lab in September 2025. We found no NYSE or Nasdaq listing for any of the Korean companies in the table, so for them the listed route runs through Seoul.
The table also shows what each purchase actually buys. A share of Estée Lauder holds Dr.Jart+ as one brand inside a large US company, and Innisfree sits under a holding company, not as a stock of its own.
Owning a brand owner such as APR or VT ties the investment to one or a few product lines. A contract manufacturer makes products for many brands, so its holders may depend less on any one of them staying popular, though we have no figures on how concentrated their customers are.
The export boom
Korea's total cosmetics exports, to all countries, reached $1.51 billion in September 2026, a monthly record, and $1.44 billion in October, up 57.5% from a year earlier, according to the trade ministry. Exports to the US alone were $1.45 billion in the first half of 2026, 41.5% more than a year before.
Those totals include the private brands in the table, so a strong export month does not directly tell a shareholder how any listed company did. Company results are the place to check that.
APR is the clearest listed case of US exposure, though it does not report US revenue separately. Its 2025 revenue more than doubled to ₩1.53 trillion (about $1.13 billion), with 80% from overseas. North America was 46% of its sales in the third quarter of 2026, so almost half of the business its holders own depends on North American demand.
During Amazon's Prime Day in June, the analytics firm Market Defense estimated Medicube's share of beauty sales at 13.2%; BeautyMatter published that analysis as partner content. If that estimate is close, Amazon is a large channel for Medicube alongside the store chains above, though the figure covers one event.
Which K-beauty stocks rose in 2026

The two contract manufacturers led: Korea Kolmar rose 70% and Cosmax 61%. Silicon2, the one distributor in the chart, fell.
Five of the seven brand owners in this group fell. VT, the maker of Reedle Shot, fell 43%.
Even APR, which ended the period up 9%, shows how sharply a stock built on one main brand can swing. It hit its 2026 closing high of ₩464,500 on August 31 and closed at ₩251,500 on November 11, 46% lower, so a buyer at the August 31 close who held to November 11 lost almost half, in won terms.
Amorepacific rose 8%. Its 2025 revenue grew 9.5% to ₩4.25 trillion and operating profit 52% to ₩335.8 billion, with Americas sales up 20%.
In this group, the manufacturers outperformed the brand owners in 2026. One partial year of share prices does not show that export growth caused the gap, and the chart is in won, so a US holder's dollar return also moved with the exchange rate.
For US investors
How to buy K-beauty stocks from the US
Sources and notes
- Ministry of Food and Drug Safety, 2025 cosmetics export figures. mfds.go.kr
- Ministry of Trade, Industry and Resources, monthly export reports (2026.10.01, 2026.11.01). motir.go.kr
- First-half 2026 cosmetics exports, Ministry of Food and Drug Safety, as reported by Cosin Korea (2026.07)
- APR press release on 2025 results (2026.02.04). tools.prnewswire.com
- The Korea Herald, APR third-quarter 2026 results (2026.11.01). koreaherald.com
- BeautyMatter partner content, Market Defense analysis of Amazon Prime Day 2026 beauty sales. beautymatter.com
- Amorepacific, 2025 results (2026.02.06). apgroup.com
- Goodai Global company history. goodai-global.com
- SEC, Guinness Atkinson post-effective amendment for KBTY (2026.10.28)
- Korea Exchange closing prices (2025.12.30 to 2026.11.11); returns are our calculation and exclude dividends
Won converted at ₩1,350 per dollar.
Cover photo: an Olive Young store in Korea, by Pkccccj, CC BY-SA 4.0, via Wikimedia Commons.
For information only, not investment advice. See our full disclaimer.
Update history
- Nov 13, 2026 Rewrote each section around what the facts mean for an investor who wants K-beauty exposure: what private ownership leaves out, the difference between owning a brand and owning a contract maker, why export totals do not translate into any one company's profit, and what the share moves showed about single-brand risk.
Corrections and changes to facts are listed here. See our editorial policy.